1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:dAVF characteristics
All Patients (n = 178) dAVF and CVT (n = 55)a dAVF Only (n = 123)b Cognard dAVF classification (n/N) (%) Benign I 58/178 (33) 23/55 (42) 35/123 (28) IIa 28/178 (16) 12/55 (22) 16/123 (13) Aggressive IIb 25/178 (14) 16/55 (29) 9/123 (7) IIa+b 15/178 (8) 8/55 (15) 7/123 (6) III 33/178 (19) 6/55 (11) 27/123 (22) IV 40/178 (22) 4/55 (7) 36/123 (29) V 2/178 (1) 0/55 2/123 (2) dAVF treatment type (n/N) (%) Conservative 61/178 (34) 42/55 (39) 38/123 (31) Endovascular only 113/178 (63) 36/55 (65) 77/123 (63) Surgical resection only 8/178 (4) 2/55 (4) 6/123 (5) Endovascular + surgical resection 14/178 (8) 5/55 (9) 9/123 (7) Endovascular + surgical resection + stereotactic radiation therapy 2/178 (1) 2/55 (4) 0/123